Your browser is out of date

With an updated browser, you will have a better Medtronic website experience. Update my browser now.

×

Skip to main content

EVOLUT PRO+ SYSTEM Transcatheter Aortic Valve Implantation (TAVI)

The next generation EvolutTM PRO+ transcatheter aortic valve system provides industry-leading hemodynamics — allowing your patients to return to activity faster.1,2,3 

DOWNLOAD BROCHURE

Overview

Meet the Evolut PRO+ SYSTEM

icon for advanced sealing

ADVANCED 
SEALING

 

icon for lowest delivery profile

LOW DELIVERY 
PROFILE

icons

HEMODYNAMIC 
PERFORMANCE

PRODUCT DETAILS

Treat more
Patients

evolut pro
tavi pro plus

Leadership
In Valve Design

Control
During Deployment

enevopro

EXPECT MORE OPTIMIZE PRO STUDY


  8.8% 

PERMANENT PACEMAKER RATE AT 30 DAYS3


  0% 

MODERATE/SEVERE PVL AT DISCHARGE3


  0 DEATHS

AND DISABLING STROKES AT 30 DAYS3


  8.1% mm Hg

GRADIENT AT DISCHARGE

EXPERTS CORNER

RESOURCES

MANUALS AND TECHNICAL GUIDES

Access instructions for use and other technical manuals in the Medtronic Manual Library. Search by the product name (e.g., Evolut) or model number.

How Evolut can treat more patients?

CONTACT US

Low risk
Indication 

Learn More

Bicuspid 
Indication

Learn More
*

Broadest annulus range based on CT derived diameters.

1

Bleiziffer S, Eichinger WB, Hettich I, et al. Impact of patient-prosthesis mismatch on exercise capacity in patients after bioprosthesis aortic valve replacement. Heart. May 2008;94(5):637-641.

2

van Slooten YJ, van Melle JP, Freling HG, et al. Aortic valve prosthesis-patient mismatch and exercise capacity in adult patients with congenital heart disease. Heart. January 2016;102(2):107-113.

3

Pibarot P, Dumesnil JG, Jobin J, Cartier P, Honos G, Durand LG. Hemodynamic and physical performance during maximal exercise in patients with an aortic bioprosthetic valve: comparison of stentless versus stented bioprostheses. J Am Coll Cardiol. November 1, 1999;34(5):1609-1617.

4

Up to 80% deployment. The valve can be partially or fully recaptured up to three times prior to the point of no recapture. Third attempt must be a complete recapture and retrieval from patient.

DISCLAIMER

The material on this website should not be considered the exclusive source of information, it does not replace or supersede information contained in the device manual(s). Please note that the intended use of a product may vary depending on geographical approvals.

See the device manual(s) for detailed information regarding the intended use, the implant procedure, indications, contraindications, warnings, precautions, and potential adverse events.

For a MRI compatible device(s), consult the MRI information in the device manual(s) before performing a MRI. If a device is eligible for eIFU usage, instructions for use can be found at Medtronic’s website manuals.medtronic.com.

Manuals can be viewed using a current version of any major internet browser. For best results, use Adobe Acrobat® Reader with the browser.

Medtronic products placed on European markets bear the CE mark and the UKCA mark (if applicable). For any further information, contact your local Medtronic representative.

© 2024 Medtronic. All rights reserved, Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic.

™*Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.